Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 1/24/15  and contains information from public web pages.

Dr. Doug Broeska

Wrong Dr. Doug Broeska?

Owner

Local Address: Winnipeg, Manitoba, Canada
Regenetek Research
 
Background

Employment History

  • PhD Medical Researcher and Chief Executive Officer
    Regenetek Research
  • President
    The CliniCard Inc
  • Chief Executive Officer
    The CliniCard Inc
  • Chief Executive Officer
    Regenetek Cellular Technologies Inc.

Board Memberships and Affiliations

  • Founder
    Regenetek Research

Education

  • PhD
    University of Manitoba
  • BSc
    University of Manitoba
  • PhD
    Brightland University
40 Total References
Web References
Broeska said he ...
www.winnipegfreepress.com, 24 Jan 2015 [cached]
Broeska said he personally funded some of the study's startup costs.
A scan of Doug Broeska's degree in philosophy from Brightland University.
Enlarge Image
A scan of Doug Broeska's degree in philosophy from Brightland University.
After days of silence, the Winnipeg medical researcher who charged multiple sclerosis patients thousands of dollars for overseas stem-cell treatment says he's been "unfairly accused and victimized by inaccurate media reporting" and looks forward to clearing his name.
In a statement sent to local media Friday morning, Doug Broeska, owner of Regenetek Research, said media reports he falsified his credentials, overstated the effects of the stem-cell clinical trial, failed to follow up with patients and was recently removed from the study are false.
He said he stands by his role in the "case-based study" where his job was to track patients for followup. He said he has not breached ethical standards and did not give medical advice to patients.
'Dr. Broeska regrets any misperception that may have resulted from referencing a PhD from the University of Manitoba on his LinkedIn page'
Broeska also released a notarized copy of his PhD certificate from Brightland University, which is not accredited in Canada, the United States or the United Kingdom. Brightland's website includes no phone numbers, no names of senior administrators or location information, spells the school name incorrectly in one reference and is linked to a well-known degree mill operator.
Broeska's degree certificate, notarized by Liya Akalu in Washington, D.C., includes a stamp saying the oath was sworn before her on Dec. 22, 2015, a date still nearly 11 months away.
Broeska's spokesman, David MacKay of Winnipeg public relations firm ResultzPR, said the date was an error made by the notary, and Broeska is awaiting a correction.
...
Broeska has so far refused to provide a copy of his dissertation, saying Friday releasing it is up to his lawyer.
Broeska originally claimed to have a bachelor of science degree and a PhD from the University of Manitoba. Neither is true.
"Dr. Broeska regrets any misperception that may have resulted from referencing a PhD from the University of Manitoba on his LinkedIn page," said the statement. "He did attend three years of classes at the University of Manitoba but did not receive a degree there."
Broeska also said it's not uncommon to ask patients to pay for clinical trials, which are voluntary. And, he disputed word this week from Regenetek's Indian partner, Surjo Banerjee of Genesis Ltd., the firm had ended dealings with Regenetek.
"The allegations against Dr. Broeska have not been proven, or even substantiated," said MacKay in an email.
...
"Dr. Broeska has not received any indication from contacts in India that Genesis Ltd. is cutting ties with Regenetek Research."
Broeska also said he personally funded some of the study's startup costs and reiterated Regenetek is a not-for-profit company. He said some patients had their treatment subsidized. "The bottom line is that Regenetek has never rejected a participant because they could not pay the full amount," said Broeska. "Clearly, if Regenetek was conducting medical tourism, it would not accept participants who could not pay their fee in full."
Broeska said he is not aware of any RCMP investigation into Regenetek, or one by the Canada Revenue Agency. He said two people who have filed RCMP complaints about Regenetek "were not enrolled in the study and may have a competitive financial motive to try to diminish the company's achievements and tarnish its reputation."
Doug ...
www.winnipegfreepress.com, 23 Jan 2015 [cached]
Doug Broeska
Enlarge Image
Doug Broeska (LINKEDIN)
...
In a statement sent to local media Friday morning, Doug Broeska, owner of Regenetek Research says media reports that he falsified his credentials, overstated the effects of the stem cell clinical trial, failed to follow up with patients and was recently asked to step down as the study's researcher are false.
He said he stands by his role in the "case-based study" where his job was to track patients for follow-up. He said he has not breached ethical standards and did not give medical advice to patients.
He also enclosed a notarized copy of his PhD certificate from Brightland University, which is not accredited in Canada, the United States or the United Kingdom. Brightland’s website includes no contact or location information, spells “Brightland†incorrectly and is linked to a well-known degree mill operator
He also enclosed a notarized copy of his PhD certificate from Brightland University, which is not accredited in Canada, the United States or the United Kingdom. Brightland's website includes no contact or location information, spells "Brightland" incorrectly and is linked to a well-known degree mill operator.
Broeska's degree certificate, notarized by Liya Akalu, a notary public in Washington, D.C., includes a stamp saying the oath was sworn before her Dec. 15, 2015, a date that has not yet occurred.
Broeska originally claimed to have a BSc and a PhD from the University of Manitoba. Neither is true.
"Dr. Broeska regrets any misperception that may have resulted from referencing a PhD from the University of Manitoba on his LinkedIn page," said the statement. "He did attend three years of classes at the University of Manitoba but did not receive a degree there."
Broeska also said it's not uncommon to ask patients to pay for clinical trials, which are voluntary.
"There is significant cost to conduct the research and administer the treatment and follow up especially since the research is being conducted at a hospital in Pune, in India," said Broeska. "The reason why India was selected is because it has enabling legislation that permits and supports this method of research. Canada and the U.S. do not have medical regulations that support private stem cell treatment trials. These are the reasons why Health Canada is not involved in overseeing this research."
Broeska also said he personally funded some of the study's startup costs, and reiterated that Regenetek is a not-for-profit company. He said some patients had their treatment subsidized.
"The bottom line is that Regenetek has never rejected a participant because they could not pay the full amount," said Broeska. "Clearly, if Regenetek was conducting medical tourism it would not accept participants who could not pay their fee in full."
Broeska said he is not aware of any RCMP investigation into Regentek, or one by the Canada Revenue Agency. He said two people who have filed RCMP complaints about Regenetek "were not enrolled in the study and may have a competitive financial motive to try to diminish the company's achievements and tarnish its reputation."
Statement from Doug Broeska
...
Updated on Friday, January 23, 2015 at 10:57 AM CST: Adds statement from Broeska
Doug Broeska is a PhD ...
www.ccsviclinic.ca, 1 Nov 2012 [cached]
Doug Broeska is a PhD Medical Researcher and CEO of Regenetek Inc, a Canadian Biotech Research firm working with several hospitals and clinics world-wide to develop medical procedural protocols for neurodegenerative disease management.
CHRIS BOLIN / for THE WINNIPEG ...
www.winnipegfreepress.com, 23 Jan 2015 [cached]
CHRIS BOLIN / for THE WINNIPEG FREE PRESS Lee Chuckry, who has MS, took part in a stem-cell trial run by Doug Broeska (left)and Regenetek Research. He quit taking a drug to receive the treatment in India. After returning home and failing to get answers, he eventually became one of Regenetek�s most vocal critics.
...
CHRIS BOLIN / for THE WINNIPEG FREE PRESS Lee Chuckry, who has MS, took part in a stem-cell trial run by Doug Broeska (left)and Regenetek Research.
...
Doug Broeska, founder of Winnipeg-based Regenetek Research and the clinical trial's principal investigator, told Chuckry that Tysabri would damage the effectiveness of the implanted stem cells.
...
Chuckry knew Broeska was not a physician, but believed Broeska had a PhD and was a bona fide health researcher.
...
Chuckry spent 10 days trying to get in touch with Broeska to find out whether going back on his MS medication, this time a steroid called prednisone, would interfere with the effectiveness of his newly implanted stem cells.
...
"Doug has made himself out to be some sort of god, and people have actually fallen for it," said Chuckry.
...
In an email to the Free Press, Broeska said he never gave medical advice.
"At no time has Regenetek represented that it was providing medical care during any portion of the clinical study," he wrote.
Doug Broeska, known to patients ...
www.winnipegfreepress.com, 19 Jan 2015 [cached]
Doug Broeska, known to patients as "Dr. Doug," claimed the treatment was "curative" and that every patient saw significant benefit from the treatment. Many did, but, a Free Press investigation found at least a half-dozen patients saw no effects from their treatments in India and received no follow-up, which is common in a clinical trial. They are angry and believe they have been duped.
Until recently, Broeska was the principal investigator on the clinical trial. He claimed to have a BSc and a PhD, first from the University of Manitoba. Then he claimed to have a PhD from "Brightland University."
He does not hold any degree from the U of M, and Brightland University does not exist.
Brightland University has a barebones website that appears phony, misspells "Brightland" and includes no contact information, such as an address, for the school. An investigation into the website's architecture showed links to University Degrees Program, which was a well-known degree mill operating dozens of fraudulent institutions.
Broeska also claimed to be a member of the International Cellular Medicine Society and to have approval for his clinical trial from "several" ethical panels.
...
The College of Physicians and Surgeons of Manitoba, which first became aware of Broeska and his MS therapies in 2011, has so far been hands-off.
...
In emails to the Free Press, other media and to patients, Broeska has repeatedly said he received a PhD, never offered medical advice to patients and that the clinical trial is a legitimate, duly registered study that is based in India.
She said she's shocked by news Broeska inflated his credentials, overstated the effects of the stem cell treatment and was asked recently by an Indian ethics committee to resign as the study's principal investigator because he put patient safety at risk.
...
While many Regenetek patients saw their MS symptoms shrink, many others did not, and began raising questions about Broeska and his treatment.
Broeska was in Trinidad last week, meeting with medical researchers from India to open another clinic.
Hauch was in Trinidad last week with Broeska but said she has no involvement in plans to expand the stem cell clinic to the Caribbean country. She said she travelled to Trinidad to meet with representatives from Inamdar Hospital in Pune to discuss plans for a companion study on physiotherapies for stem cell patients. That study was to be done in conjunction with the University of Winnipeg, but the school cut ties with Regenetek last week following a Free Press investigation.
Manitoba company records list Hauch as a director, along with Broeska, of CliniCard Inc, a company related to Regenetek and located in the same office on Chevrier Boulevard.
...
In emails to the Free Press, the CBC and patients in recent days, Broeska has vigorously denied the allegations about him and Regenetek.
He said he stands behind his company's role in the clinical study, which he said was only to track patients upon their return from India.
"We are scientists simply tracking the progress of participants who have chosen to attempt innovative therapy options and to have their results noted by us for scientific study," said Broeska in a statement.
Other People with the name "Broeska":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.